|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 491/056 | |
| A61K 31/519 | |||
| A61P 35/00 |
| (11) | Number of the document | 2392576 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09793788.2 |
| Date of filing the European patent application | 2009-07-07 | |
| (97) | Date of publication of the European application | 2011-12-07 |
| (45) | Date of publication and mention of the grant of the patent | 2016-02-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2009/000773 |
| Date | 2009-07-07 |
| (87) | Number | WO 2010/003313 |
| Date | 2010-01-14 |
| (30) | Number | Date | Country code |
| 200810132631 | 2008-07-08 | CN | |
| 200810132458 | 2008-07-17 | CN | |
| 200810188272 | 2008-12-23 | CN |
| (72) |
WANG, Yinxiang, CN
DING, Lieming, CN
TAN, Fenlai, CN
HU, Yunyan, CN
HE, Wei, CN
HAN, Bin, CN
LONG, Wei, CN
LIU, Yong, CN
AL, Haima, CN
ZHANG, Don, US
DAVIS, Charles, US
XIE, Guojian, US
|
| (73) |
Beta Pharma, Inc.,
5 Vaughn Drive, Suite 106, Princeton, NJ 08540,
US
|
| (54) | ICOTINIB HYDROCHLORIDE, SYNTHESIS, CRYSTALLOGRAPHIC FORM, MEDICAL COMBINATION, AND USES THEREOF |
| ICOTINIB HYDROCHLORIDE, SYNTHESIS, CRYSTALLOGRAPHIC FORM, MEDICAL COMBINATION, AND USES THEREOF |